FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
EIRS/483s

DoJ Preferring Deferred Prosecution Agreements: Attorneys

Lawyers from Troutman Pepper say that two recent medical product cases could be a harbinger of more Department of Justice deferred prosecution agreeme...

latest-news-card-1
Human Drugs

Panel to Weigh OTC Phenylephrine Efficacy

FDA announces a 4/12 Nonprescription Drugs Advisory Committee meeting to discuss the adequacy of efficacy data available for over-the-counter use of o...

latest-news-card-1
Human Drugs

Exelixis Renal Cell Carcinoma Study Misses Endpoint

Exelixis says its Phase 3 CONTACT-03 study evaluating the companys Cabometyx (cabozantinib) in combination with atezolizumab versus cabozantinib alone...

latest-news-card-1
Federal Register

Drug Continuous Manufacturing Guidance

Federal Register notice: FDA makes available a final guidance entitled Q13 Continuous Manufacturing of Drug Substances and Drug Products.

latest-news-card-1
Federal Register

Guide on Monoclonal Antibody Development

Federal Register notice: FDA makes available a draft guidance entitled Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Pr...

latest-news-card-1
Human Drugs

Veru EUA Request for Covid Drug Denied

FDA declines a Veru request for an Emergency Use Authorization for sabizabulin, a microtubule disruptor for treating Covid-19 hospitalized adult patie...

latest-news-card-1
FDA General

Lilly Gets Expanded Indication for Verzenio

FDA approves an expanded indication for Eli Lillys Verzenio (abemaciclib), in combination with endocrine therapy for the adjuvant treatment of adult p...

latest-news-card-1
Medical Devices

FloSpine 3D-Printed Interbody Cage Cleared

FDA clears a FloSpine 510(k) for its a 3D-printed titanium Ti-Largo cervical interbody cage system to support the spine after a cervical collapse or a...

latest-news-card-1
Medical Devices

Convatecs Extracellular Matrix Wound Care Cleared

FDA cleared a Convatec 510(k) for its InnovaMatrix PD particulate placental extracellular matrix medical device for wound management.

latest-news-card-1
Human Drugs

CDER 2022 Drug Safety Priorities Report Out

FDA publishes the CDER Drug Safety 2002 Priorities Report reviewing the many drug safety activities the Center undertook in 2022.